Cargando…
Remitting Seronegative Symmetrical Synovitis with Pitting Edema: A Case Report of an Immune-Related Adverse Event following Surgery
Immune checkpoint inhibitors (ICIs) have emerged as a novel class of anti-neoplastic agent in oncology. Their integration into practice has been accompanied by “immune-related adverse events” (irAEs) wherein off-target immune responses damage healthy tissues. Severe irAEs can cause irreversible orga...
Autores principales: | Janse van Rensburg, Helena J., Spiliopoulou, Pavlina, Makhzoum, Anas, Healy, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625819/ https://www.ncbi.nlm.nih.gov/pubmed/37933314 http://dx.doi.org/10.1159/000532004 |
Ejemplares similares
-
Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis
por: Matsugasumi, Toru, et al.
Publicado: (2020) -
Remitting seronegative symmetrical synovitis with pitting edema: a case report
por: Tanaka, Yasushi, et al.
Publicado: (2022) -
Syndrome of remitting seronegative symmetrical synovitis with pitting edema: A case series
por: Varshney, AN, et al.
Publicado: (2015) -
Remitting symmetrical seronegative synovitis and pitting edema syndrome with concomitant adenocarcinoma of the lung
por: Karahan, S
Publicado: (2019) -
Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Complicated with Organizing Pneumonia
por: Hosoda, Chiaki, et al.
Publicado: (2020)